U.S. Healthcare Services Stock News

How WisdomTree stock has been performing WisdomTree (WT) has drawn investor attention recently as the stock has moved over multiple timeframes, including a 2.3% gain in the latest session and a year to date return above 50%. See our latest analysis for WisdomTree. The recent 1-day share price return of 2.29% and 30-day share price return of 5.03% sit within a much stronger backdrop, with a year-to-date share price return of 53.64% and a 1-year total shareholder return of 103.34% pointing to...

Dorchester Minerals, L.P. has reported past first‑quarter 2026 results, with sales of US$849,000, revenue of US$58.88 million and net income of US$28.26 million, all higher than a year earlier. The partnership’s earnings per unit rose to US$0.59, highlighting how its royalty and net‑profits interests can amplify benefits from stronger oil markets. We will now examine how Dorchester Minerals’ improved first‑quarter profitability, underpinned by higher royalty‑linked revenue, shapes its...

At its Annual Meeting held on May 12, 2026, Centene appointed Daniel Finke as Group President of Medicaid and Marketplace and Michael Carson as Group President of Medicare and Specialty to oversee its core government and specialty businesses. These leadership appointments underline Centene’s effort to sharpen operational efficiency across Medicaid, Marketplace, Medicare and specialty lines, potentially influencing how it executes on its existing growth and margin recovery plans. We’ll now...

Walmart (NasdaqGS:WMT) rolls out ASUS military-grade Chromebooks and Chromebook Plus models nationwide, featuring AI tools such as Google Gemini and Magic Editor. The retailer introduces a limited-edition hydration collection from TAL, backed by influencers and positioned as a premium, trend-focused offering. Buda Juice expands beyond Texas through Walmart stores, widening access to fresh and functional beverages in new regions. For Walmart, these moves touch several core lines of business...

Why Goosehead Insurance Stock Is On Investors’ Radar Goosehead Insurance (GSHD) has drawn fresh attention after recent share price swings, with the stock up about 14% over the past week but down around 7% for the month. See our latest analysis for Goosehead Insurance. That short burst of momentum comes after a tougher stretch, with the 30 day share price return down 7.36% and the year to date share price return down 41.04%, while the 1 year total shareholder return is down 61.58%. Recent...

In early May 2026, Guardant Health reported first-quarter revenue of US$301.67 million versus US$203.47 million a year earlier, while its net loss widened to US$112.08 million and basic loss per share from continuing operations was US$0.85. On the same day, the company raised its 2026 revenue guidance to US$1.30–US$1.32 billion on the back of strong uptake for its FDA-approved Shield colorectal cancer screening test and broader oncology portfolio, underlining management’s confidence in the...

Northwest Bancshares (NWBI) has drawn investor attention after recent trading aligned with its solid one year and multi year total returns. This has prompted a closer look at how its regional banking business and current valuation fit together. See our latest analysis for Northwest Bancshares. Recent share price moves have been relatively steady, with the stock holding at around $13.66 after a modest 30 day share price return of 1.56%, while the 1 year and multi year total shareholder returns...

In recent days, Elevance Health has seen its investment case reinforced by a sector-wide upgrade from Deutsche Bank, which moved the company to a "Buy" rating as part of a more positive stance on managed care amid expectations of improved pricing discipline and margin recovery. Alongside this, a steady stream of routine deferred stock unit grants to board members underscores ongoing alignment between Elevance’s governance, its diversified Carelon-led growth ambitions, and the healthcare...

Unusual options activity in BancFirst (BANF) has put the stock on many investors’ screens, with elevated implied volatility coinciding with a recent earnings beat and generally more positive analyst sentiment. See our latest analysis for BancFirst. Recent trading reflects this renewed attention, with the share price at $108.24 and a 1-year total shareholder return that declined 15.04%, while the 3-year and 5-year total shareholder returns of 31.34% and 77.84% point to a stronger longer term...

UFP Industries (UFPI) is back in focus after its latest quarter showed declines in revenue and earnings per share, a miss versus analyst expectations that left the stock lagging other building materials peers. See our latest analysis for UFP Industries. The recent miss and weaker quarter have contributed to share price pressure, with UFP Industries’ 30 day share price return down 17.33% and its 1 year total shareholder return down 20.72%. This signals fading momentum despite slightly positive...

Why Monarch Cement (MCEM) is on investors’ radar Monarch Cement (MCEM) has drawn fresh attention after recent share price moves, with the stock up about 14% over the past month and roughly 15% over the past 3 months. See our latest analysis for Monarch Cement. Short term, the share price has eased slightly over the past week, but the 30 day share price return of 14.11% and year to date gain of 19.41% sit against a very strong 5 year total shareholder return of 257.12%, which suggests that...

Interparfums (IPAR) has drawn fresh attention after its audit committee replaced Forvis Mazars with Grant Thornton as independent auditor. This move follows previously disclosed material weaknesses in internal controls over financial reporting. See our latest analysis for Interparfums. The auditor transition comes at a time when the share price has eased, with a 1 month share price return of 12.49% and a 3 month share price return of 14.48%, while the 1 year total shareholder return is down...

In May 2026, Gilead Sciences completed multiple fixed‑rate, callable senior unsecured bond offerings totaling about US$3.00 billion, with maturities from 2028 to 2034 and coupons ranging from 4.25% to 4.90%, supported by a broad syndicate of co‑lead underwriters including J.P. Morgan, Goldman Sachs, Morgan Stanley, and others. These financings, coming shortly after Gilead reported higher first‑quarter revenue and net income year on year and raised its 2026 product sales guidance, highlight...

Multiple securities class action lawsuits have been filed against Coty (NYSE:COTY). The actions follow the abrupt departure of CEO Sue Y. Nabi and the withdrawal of Coty's 2026 financial guidance. Investors allege management made misleading statements about business conditions and softness in key segments. Coty operates in the global beauty and personal care industry, where brand strength, consumer trends, and distribution reach play a central role. For investors, management stability and...

McGrath RentCorp recently completed a new US$725 million five-year credit facility maturing in 2031, replacing its prior US$650 million line of credit and earmarking the expanded capacity for working capital, capital expenditures and other general corporate uses. The upsized and extended facility, backed by a syndicate led by Bank of America with U.S. Bank and Wells Fargo, highlights lenders’ willingness to support McGrath RentCorp’s balance sheet flexibility and future investment...

What Microvast’s Latest Earnings Tell You Microvast Holdings (MVST) has drawn fresh attention after reporting first quarter 2026 results, with sales, net income and earnings per share all lower than a year earlier, sharpening the focus on the stock’s recent pullback. See our latest analysis for Microvast Holdings. The latest earnings report appears to have intensified existing pressure on Microvast’s share price. It is trading at US$1.20 after a 1-day share price return of down 4%, with the...

In the past week, MercadoLibre reported first-quarter 2026 results showing revenue of US$8.85 billion versus US$5.94 billion a year earlier, while net income eased to US$417 million and earnings per share also declined as heavier investments and higher loan-loss provisions weighed on profitability. The company’s leadership has framed this margin compression as a deliberate choice to support long-term ecosystem growth, ramping up spending on logistics, free shipping in Brazil, and its...

Vail Resorts has previously announced it would release its fiscal third quarter 2026 results after market close on June 8, 2026, followed by a management conference call and webcast. This earnings release takes on added importance because it follows reports of lower skier visits and reduced full‑year net income guidance, heightening focus on how current trends align with prior expectations. Next, we will examine how the upcoming earnings call, set against softer skier visits, may influence...

Earlier this month, Regency Centers Corporation’s Board declared quarterly cash dividends of US$0.390625 per share on its Series A preferred stock and US$0.367200 per share on its Series B preferred stock, both payable on July 31, 2026, to shareholders of record as of July 16, 2026. Alongside these preferred dividends, Regency Centers released an updated investor presentation outlining its strategic priorities and retail real estate positioning, aiming to reinforce confidence in its...

Tyra Biosciences (TYRA) stock is back in focus after first quarter results showed a wider net loss, a strong cash position, ongoing Phase 2 trials for dabogratinib and fresh institutional buying interest. See our latest analysis for Tyra Biosciences. The stock has cooled off in recent sessions, with the share price down 5.3% over the last day and 5.0% over the past month, but a 26.1% year to date share price return and a very strong 1 year total shareholder return of 238.5% point to momentum...

GameStop (GME) is back in focus after a fresh bout of trading volatility, prompting investors to reassess what the current US$22.10 share price and recent return patterns suggest about the stock’s risk and reward profile. See our latest analysis for GameStop. Recent trading has been choppy, with a 1-day share price return of 0.87% at US$22.10, compared with a 30-day share price return down 9.98% and a 1-year total shareholder return down 21.57%. This suggests momentum has been fading after...

Axon Enterprise (AXON) is back in focus after its Q1 2026 report, which beat analyst expectations, came with higher full-year revenue guidance, and highlighted strong momentum in connected devices and AI-driven public safety tools. See our latest analysis for Axon Enterprise. Despite the strong Q1 earnings beat and the raised 2026 revenue outlook, Axon’s share price is down 30.37% year to date and its 1 year total shareholder return is down 47.18%. However, the 3 year total shareholder return...

Plug Power has been selected to supply its GenEco PEM electrolyzer technology to the 30-megawatt Barrow Green Hydrogen project in the UK. The Barrow project is the first of three UK government supported hydrogen developments to reach final investment decision and move into execution. This contract marks a step in Plug Power's efforts to deploy its electrolyzer systems at scale in international markets. For investors watching NasdaqCM:PLUG, this contract sits against a share price of $3.31...

If you are wondering whether Home Depot at US$302.44 is starting to look like value after a weaker share price, the next step is to see what the fundamentals say about that price tag. The stock has fallen 2.6% over the past week and is down 13.4% over the last month, with a 12.5% decline year to date and a 17.8% decline over the past year, even though the 3 year and 5 year returns stand at 10.6% and 7.9% respectively. Recent coverage has focused on how Home Depot fits into broader...